Preferred adjunctive applications of the KD include genetic epilepsies, such as SCN1A-related Dravet syndrome, TSC1/TSC2-related tuberous sclerosis complex, and UBE3A-related Angelman syndrome. This evidence concerns the gene TSC2 and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.